| Ytd | -57.19% | |
| 1y | -30.72% |
| Open | 3.78 | Prev Close | 3.50 | Low | 3.49 | High | 3.94 | Mkt Cap | 91.54M |
| Vol | 229.15K | Avg Vol | 79.09K | EPS | -1.23 | P/E | -2.88 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 4.15 | 200-d Avg | 7.02 | 1yr Est | 0.00 |
NTHI News
Houston, Texas--(Newsfile Corp. - August 11, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) is s
Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's
NeOnc Technologies (NASDAQ:NTHI) reported quarterly losses of $(0.58) per share which missed the ana
NeOnc (Nasdaq: NTHI) will host an investor conference call and webcast on Wednesday, August 12, 2026
CALABASAS, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI
Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 28.6% to $0.64 during Thursday's after-
NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a clinic
CALABASAS, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI
Three emerging biotechnology companies, Can-Fite (NYSE: CANF), NeOnc (NASDAQ: NTHI), and PMGC (NASDA
DENVER, June 24, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NASD
Authorization covers all three NEO100 programs across adult Phase 1 through Phase 2, plus pediatric
International Regulatory Validation Has Preceded Several Recent FDA Success Stories, Though Signific
DALLAS, June 17, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings (NASDAQ: NTHI) is rapidly emer
DENVER, June 16, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) – NeOnc Technologies Holdings (NASDA
Clearance enables Phase 2 evaluation of NEO212, the Company's oral perillyl alcohol-temozolomide con
New Funding Structure Includes Redemption Rights, Ownership Limitations, and Conversion Floor as Inv
NeOnc Technologies Advances Novel Neuro-Oncology Therapies Targeting Glioblastoma and Other Hard-to-
DENVER, May 29, 2026 (GLOBE NEWSWIRE) -- (www. 247marketnews. com) - When most investors think about
DENVER, May 19, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com ) – NeOnc Technologies (NASDAQ:NTHI
CALABASAS, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI)
CNS Pharmaceuticals (NASDAQ:CNSP) is back on every biotech watchlist after a 242.36% one-week ramp t
DENVER, May 07, 2026 (GLOBE NEWSWIRE) -- (www.247marketnews.com and NeOnc Technology) - The biotech
